RxDoctor Payments Data

Varunsiri Atti, MD

Cardiovascular Disease · Odessa, TXNPI 1336660984

Payments from drug & device makers

$9,306in general payments, 2019–2025

Across 141 payments — averaging $66.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$3K
  • Medtronic$2K
  • Boston Scientific$1K
  • Abbott$723
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$629
  • W. L. Gore & Associates, Inc.$489
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$2,09322%
  • Food & beverage$6,19567%
  • Education$1,01811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,306 in reported general payments places this provider in the 70th percentile of 1,515 cardiovascular disease providers in Texas.

See all cardiovascular disease providers in Texas

Medicare billing

Part B allowed, 2024
$49,493
Medicare patients
549
Services billed
1,294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium68$658
ClopidogrelClopidogrel Bisulfate41$500
Metoprolol Succinate17$215
Nitroglycerin14$161
Metoprolol Tartrate36$156
Isosorbide Mononitrate ErIsosorbide Mononitrate14$151
Amlodipine Besylate30$142
Rosuvastatin Calcium14$130
Losartan Potassium12$109
Furosemide29$87
Carvedilol11$64
Lisinopril13$31

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Odessa

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →